-

 Sheridan Company issued 5900 shares of its $10 par value common stock having a fair value of $25 per share and 8400 shares of its $10 par value preferred stock having a fair value of $20 per share for a lump sum of $252000. The proceeds allocated to the preferred stock is О $117813 $169800 О $168000 О $134187

Comments

Post a Comment

Popular posts from this blog

-
 Which of the following is not an acceptable method of determining the required annual payment of federal income tax for corporations? A) 100 percent of the prior year's tax liability (with a few exceptions) B) 100 percent of the current year's tax liability C) 100 percent of the estimated current year tax liability using the annualized income method D) All of the choices are acceptable methods of determining the required annual payment of federal income tax for corporations. Explain. Explain.
Read more

Why Rockets Explode: Understanding the Risks and How SpaceX is Addressing Them

-
Image
Space X rocket explosion   In recent years, there has been a surge of interest in space exploration, and many companies like SpaceX have been making great strides in this field. However, one of the biggest risks associated with space travel is the possibility of rockets exploding. This is not only dangerous for astronauts but can also result in the loss of expensive equipment and resources. In this article, we will explore the reasons why rockets explode and how SpaceX is working to mitigate this risk. One of the main reasons why rockets explode is due to the complex and intricate nature of their design. Rockets are made up of thousands of parts, and even the slightest malfunction in one of these parts can have disastrous consequences. Additionally, the high pressure and temperature environments that rockets operate in can exacerbate these issues. Another factor that can contribute to rocket explosions is the use of highly volatile and flammable fuels. Rocket fuels such as liquid o...
Read more

Escitalopram StatPearls

-
  Continuing Education Activity Escitalopram is a medication used in the management and treatment of major depressive disorder and generalized anxiety disorder. It is in the selective serotonin reuptake inhibitor class of drugs. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions, adverse events) pertinent for members of the healthcare team in the management of patients with depression, anxiety, and other related conditions. Objectives: Identify the mechanism of action of escitalopram. Describe the potential adverse effects of escitalopram. Review the appropriate monitoring for therapy with escitalopram. Summarize interprofessional team strategies for improving care coordination and communication when initiating escitalopram to improve patient outcomes. Access free multiple choice questions on this topic. Go to: Indications Escitalopram...
Read more